Incannex Healthcare IXHL
NASDAQ IXHL
$3.36 -0.01 (-0.45%)
As of: Sep 9, 2026 · 12:59 PM EDT

Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)

Incannex Healthcare's (IXHL) quarterly Non Operating Income came in at $165000.0 in Q1 2026, down 84.06% year-over-year from $1.0 million in Q1 2025, and down 65.19% quarter-over-quarter from $474000.0 in Q4 2025.

Analysis

Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends

Incannex Healthcare has disclosed Non Operating Income across 5 years of filings, most recently posting $165000.0 for Q1 2026.

  • In Q1 2026, Non Operating Income fell 84.06% year-over-year to $165000.0; the TTM figure through Mar 2026 stood at -$23.0 million (down 637.02% YoY), while the FY2025 annual figure was -$23.1 million, down 298.9% from the prior year.
  • Non Operating Income came in at $165000.0 for Q1 2026 at Incannex Healthcare, down from $474000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $4.2 million in Q3 2023 to a low of -$24.1 million in Q2 2025.
  • Average Non Operating Income over 5 years is -$688857.1, with a median of $597500.0 recorded in 2022.
  • Year-over-year, Non Operating Income soared 16465.0% in 2024 and sank 826.68% in 2025.
  • Over 5 years, Non Operating Income stood at $721000.0 in 2022, then jumped by 280.31% to $2.7 million in 2023, then tumbled by 132.46% to -$890000.0 in 2024, then soared by 153.26% to $474000.0 in 2025, then tumbled by 65.19% to $165000.0 in 2026.
  • Per Business Quant data, the three most recent Non Operating Income figures were $165000.0 in Q1 2026, $474000.0 in Q4 2025, and $387000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 643.50 Bn 622.74 Bn 17.26 Bn -
2 AbbVie 440.29 Bn 433.72 Bn 12.70 Bn -
3 Merck 364.93 Bn 357.79 Bn 12.21 Bn -
4 Novartis Ag 266.65 Bn 258.96 Bn 11.24 Bn -
5 Pfizer 158.92 Bn 147.22 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn -
7 Revolution Medicines 44.32 Bn 44.32 Bn - -139.24 Mn
8 Incyte 25.32 Bn 20.78 Bn 1.57 Bn -
9 United Therapeutics 21.42 Bn 18.75 Bn 683.80 Mn 41.90 Mn
10 Incannex Healthcare 41.43 Mn 41.43 Mn - 165,000.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 165,000.00
Dec 31, 2025 474,000.00
Sep 30, 2025 387,000.00
Jun 30, 2025 -24.08 Mn
Mar 31, 2025 1.04 Mn
Dec 31, 2024 -890,000.00
Sep 30, 2024 834,000.00
Jun 30, 2024 3.31 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 2.74 Mn
Sep 30, 2023 4.17 Mn
Jun 30, 2023 20,000.00
Mar 31, 2023 80,000.00
Dec 31, 2022 721,000.00